Free Trial

Amphastar Pharmaceuticals (AMPH) Earnings Date, Estimates & Call Transcripts

Amphastar Pharmaceuticals logo
$41.11 +0.26 (+0.64%)
(As of 07:29 AM ET)
Get Amphastar Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amphastar Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AMPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amphastar Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.72$0.72$0.72
Q2 20241$0.73$0.73$0.73
Q3 20241$0.96$0.96$0.96
Q4 20241$1.02$1.02$1.02
FY 20244$3.43$3.43$3.43

Amphastar Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/7/2024Q2 2024$0.75$0.85+$0.10$0.97$171.29M$182.39M
5/8/2024Q1 2024$0.73$0.93+$0.20$1.05$171.13M$171.84M
2/28/2024Q4 2023$0.84$0.81 -$0.03$0.94$174.90M$178.11M
11/8/2023Q3 2023$0.67$1.08+$0.41$1.25$170.65M$180.56M
8/8/2023Q2 2023$0.52$0.58+$0.06$0.67$137.20M$145.71M
5/9/2023Q1 2023$0.40$0.52+$0.12$0.54$130.50M$140.02M
2/28/2023Q4 2022$0.34$0.67+$0.33$0.68$126.43M$135.02M

Amphastar Pharmaceuticals Earnings - Frequently Asked Questions

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $723.55 million.

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $137.54 million. AMPH has generated $3.00 earnings per share over the last four quarters.

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 13.62 and a forward price-to-earnings ratio of 11.44. The price/earnings-to-growth ratio is 0.87.

Amphastar Pharmaceuticals's earnings are expected to grow from $3.57 per share to $4.09 per share in the next year, which is a 14.57% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:AMPH) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners